Sleep, Diabetic Retinopathy and Melatonin
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetes Mellitus
- Diabetic Retinopathy
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Double blinded randomized controlled studyMasking: Triple (Participant, Investigator, Outcomes Assessor)Masking Description: Participants and investigators are blinded.Primary Purpose: Other
Participation Requirements
- Age
- Between 40 years and 65 years
- Gender
- Both males and females
Description
This is a randomized controlled study using melatonin for 8 weeks in patients with diabetic retinopathy on outcomes of sleep and circadian regulation
This is a randomized controlled study using melatonin for 8 weeks in patients with diabetic retinopathy on outcomes of sleep and circadian regulation
Tracking Information
- NCT #
- NCT04547439
- Collaborators
- University of Chicago
- Investigators
- Not Provided
Get Well Soon